[1] 黄如训,苏镇培﹒脑卒中[M].北京:人民卫生出版社,2001:1-2.
[2] 庄礼兴,李艳慧,江钢辉.中风病治疗与护理[M].上海:上海科学技术文献出版社,2005:71-89.
[3] Goldstein LB, Bushnell CD, Adams RJ, et al.Guidelines for the primary prevention of stroke : a guideline for healthcare professionals from the american heart association/american stroke association[J].Stroke, 2011, 42(2):517-584.
[4] 许国旺.代谢组学:方法与应用[M].北京:科学出版社,2008:1-8.
[5] Nicholson JK, Connelly J, Lindon JC, et al.Metabonomics: a platform for studying drug toxicity and gene function[J].Nat Rev Drug Discov, 2002(1):153-161.
[6] Kazuki A, Shigenori M, Misako I, et al.A metabonomic study of biochemical changes characteristic of genetically hypertensive rats based on 1H-NMR spectroscopic urinalysis[J].Hypertens Res, 2012,35(4):404-412.
[7] Zhao L, Liu X, Xie L,et al.1H-NMR-based metabonomic analysis of metabolic changes in streptozotocin-induced diabetic rats[J].Anal Sci, 2010,26(12):1277-1282.
[8] A JY, Qian SX, Wang GJ, et al.Chronic myeloid leukemia patients sensitive and resistant to imatinib treatment show different metabolic responses[J].PLoS One, 2010, 5(10):e13186.
[9] 贾伟. 医学代谢组学[M].上海:上海科学技术出版社,2011:48-51.
[10] 王桂清. 卒中的监测与防治[M].上海:上海科技教育出版社,2003:68-83.
[11] 赵建国.脑梗死(第二版)[M].北京:人民卫生出版社,2012:9-30.
[12] 付于,夏天,颜贤忠,等.芎芪合剂对脑缺血再灌注损伤大鼠兴奋性氨基酸含量及代谢组学的影响[J].中医杂志,2009,50(9):831-834.
[13] Takeuchi H, Jin SJ, Suzuki H, et al.Blockade of microglial glutamate release protects against ischemic brain injury[J].Exp Neurol, 2008,144-146.
[14] Kimelberg HK, Nestor NB, Feustel PJ.Inhibition of release of taurine and excitatory amino acids in ischemia and neuroprotection[J].Neurochem Res, 2004, 29(1):267-274.
[15] 陈晓晴,黎萍,罗小平,等.大鼠缺血缺氧过程脑皮质神经化学物质的变化[J].中山大学学报(医学科学版),2008,29(5):536-540.
[16] 冀瑞俊,贾建平,李慎茂.急性缺血性脑血管病溶栓治疗与管理[M].北京:中国协和医科大学出版社,2011:57.
[17] Castillo J, Dávalos A, Naveiro J, et al.Neuroexcitatory amino acids and their relation to infarct size and neurological deficit in ischemic stroke[J].Stroke, 1996; 27(6): 1060-1065.
[18] 黄洁,毕国荣,张德英.脑梗塞患者血浆抑制性氨基酸变化及兴奋性氨基酸的关系[J].脑与神经疾病杂志,1997,5(6):323-327.
[19] 华浩明, 伊藤崇志,邱志刚,等.牛磺酸对心血管系统作用及机理的研究进展[J].中国中药杂志,2005,30(9):653-658.
[20] 王丽娟,王勇.牛磺酸药理作用的研究进展[J].天津药学,2004,16(5):46-48.
[21] Huxtable RJ.Physiological actions of taurine[J].Physiol Rev,1992,72(1):101-163.
[22] Ghandforoush-Sattari M, Mashayekhi SO, Nemati M, et al.Changes in plasma concentration of taurine in stroke[J].Neuroscience Letters, 2011,496(3):172-175.
[23] Sun M, Xu C.Neuroprotective mechanism of taurine due to up-regulating calpastatin and down-regulating calpain and caspase-3 during focal cerebral ischemia[J].Cell Mol Neurobiol, 2008,28(4):593-611.
[24] 涂佳玉,阿基业,王广基,等.通塞脉微丸干预缺血性中风模型大鼠的血浆代谢组学研究[J].中国中药杂志,2012,37(7):1028-1033.
[25] Homocysteine Studies Collaboration.Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis[J].JAMA,2002,288(16):2015-2022.
[26] Howard VJ, Sides EG, Newman GC, et al.Changes in plasma homocyst(e)ine in the acute phase after stroke[J].Stroke,2002,33(2):473-478.
[27] 丁旭东,张贵斌,叶琳,等.血浆同型半胱氨酸与缺血性进展性脑卒中的相关研究[J].疑难病杂志,2007,6(2):73-76.
[28] Jung JY, Lee HS, Kang DG, et al.1H-NMR-based metabolomics study of cerebral infarction[J].Stroke, 2011, 42(5):1282-1288.
[29] Urenjak J, Williams SR, Gadian DG, et al.Metabolic profile of various neural cells: A basis for interpreting 1HNMR brain spectra in vivo[J].Neurochem Int, 1992,21(1): D5.
[30] 林永忠,孙长凯,肖昭扬,等.不同疗程阿托伐他汀对脑梗死患者血脂和神经功能缺损程度的影响[J].中国临床康复,2006,10(20):28-32.
[31] 李洪军,张晨.N-乙酰天门冬氨酸与卒中[J].国外医学:脑血管疾病分册, 2005, 13(3):210-212.
[32] 吴光耀,孙骏谟,田志雄,等.质子磁共振波谱对大白鼠大脑中动脉线栓模型的连续观察[J]﹒临床放射学杂志, 2002, 21(6):464-469﹒
[33] 张玉梅,张宁,周筠,等.应用磁共振波谱观察脑卒中患者的脑内代谢变化[J].中国临床康复,2005,9(33):111-113.
[34] 吴光耀,孙骏谟,田志雄.1HMRS在脑梗塞中的临床应用[J].临床放射学杂志, 2001, 20(3): 165-169.
[35] Nonaka M, Yoshimine T, Kumura E, et al.Decrease in N-acetylaspartate without commensurate accumulation of acetate in focal cerebral ischemia in rat[J].Neurol Res, 1999, 21(8): 771-774.
[36] Henry JM,Barnett JP Mohr, Bennett M Stein, et al.卒中病理生理、诊断及其治疗(第三版)[M]﹒沈阳:辽宁科学技术出版社,2001:49-55﹒
[37] 陈小铭,倪立,李金恒,等.脑脉通对大鼠局灶性脑缺血-再灌注损伤的保护作用[J]﹒医学研究生学报,2003,16(4):256-259.
[38] 陈曦,杨永霞,王淑美,等.基于NMR代谢组学研究脑脉通复方提取物对大鼠脑缺血再灌注模型的影响[J].中草药,2012,43(1):97-102.
[39] Yang M, Wang S, Hao F, et al.NMR analysis of the rat neurochemical changes induced by middle cerebral artery occlusion[J].Talanta,2012,88:136-144.
[40] 盛文利,李锐,徐晓伟,等.E-选择素介导的大鼠脑缺血再灌注后继发炎症损伤的实验干预[J].中山大学学报:医学科学版,2007,28(1):48-58﹒
[41] 付于,黄燕,黄培新,等.急性缺血性脑血管病的中药溶栓治疗与代谢组学的研究趋势[J].辽宁中医杂志,2006,33(6):662-664.
[42] Zhao CX, Cui YH, Fan Q, et al.Small dense low-density lipoproteins and associated risk factors in patients with stroke[J].Cerebrovasc Dis, 2009, 27(1):99-104.
[43] van Kooten F, van Krimpen J, Dippel DW, et al.Lipoprotein(a) in patients with acute cerebral ischemia[J].Stroke, 1996,27(7):1231-1235﹒
[44] Boden-Albala B, Kargman DE, Lin IF, et al.Increased Stroke Risk and Lipoprotein(a) in a Multiethnic Community: The Northern Manhattan Stroke Study[J].Cerebrovasc Dis, 2010, 30(3):237-243.
[45] Kargman DE, Tuck C, Berglund L, et al.Lipid and lipoprotein levels remain stable in acute ischemic stroke: the Northern Manhattan Stroke Study[J]. Atherosclerosis, 1998, 139(2):391-399.
[46] Aoki J, Uchino K.Treatment of risk factors to prevent stroke[J].Neurotherapeutics, 2011, 8(3):463-474.
[47] 涂佳玉,阿基业,文红梅,等﹒通塞脉微丸干预缺血性脑中风大鼠的脑组织代谢组学研究[J].中国药理学通报,2011,27(10):1467-1471. |
